SAN JOSE - Kyowa Hakko Kirin Co. and Biowa Inc. claim Aragen Bioscience and Transposagen Biopharmaceuticals' use of Chinese hamster ovary cell lines to develop vaccines and therapies violates three patents, in Federal Court.
Categories / Uncategorized
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
Additional Reads
-
FTC vs Facebook November 27, 2023 -
-
-
‘Stop Woke’ subpoenas October 30, 2023